Browse diseases

…overall dementia (adjusted HR (AHR) 0.90; 95% CI 0.85 to 0.95), Alzheimer’s disease (AD) (AHR 0.88; 95% CI 0.83 to 0.94), and non-vascular dementia…

… people from underserved communities remain underrepresented in dementia trials. Barriers occur at the point of initial engagement and a…

…eals when they are older may be important for the prevention of dementia.…

…ntify the top-10 research priorities in this context for future dementia care research.Methods and analysis The methodological approach …

…life instruments used include the Quality of Life in Late-Stage Dementia (QUALID), EQ-5D-3L and EQ-5D-5L instruments, ICEpop CAPability …

…Introduction Dementia imposes significant care and financial burdens on families and …

…insights that can guide research on more holistic approaches to dementia risk reduction.…

…valuation, SAFER-Dem could become a valuable tool in supporting dementia-inclusive discharge practices. Research and co-design with people living …

…rinsic symptom relief properties (No proven benefit in advanced dementia). Antiplatelet agents 7 (14.6%) Anticoagulants 7 (14.6%) Statin…

…ts All four patients exhibited core delusions in the context of dementia, with heterogeneous severity, symptom duration and treatment re…

…tool for assessing both the diagnosis and severity of delirium (Delirium Rating Scale-Revised-98 (DRS-R-98)) in people with dementia who…

…Dementia is a progressive neurodegenerative disorder characterised by co…